Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
Congress’s Medicare advisers Oct. 5 appeared close to recommending that the nine-month-old physician quality reporting system be killed.
The Merit-based Incentive Payment System, known as MIPS, is extremely complex and a $1 billion burden on doctors, staff of the Medicare Payment Advisory Commission said during a presentation at the panel’s October meeting.
No recommendations have been drafted, but the commissioners will continue discussions on MIPS at their December meeting, Commission Chairman Francis J. Crosson said. Action is needed quickly, Catherine Bloniarz, a MedPAC senior analyst, said, because the Centers for Medicare & Medicaid Services begins making MIPS adjustments to doctors’ payments in 2019, based on performance in 2017.
The commissioners appeared to be in agreement that MIPS, which began Jan. 1, needs to go, but there wasn’t a consensus on what system, if any, should replace it. Eligible doctors who don’t participate in advanced alternative payment models report quality measures under MIPS and results can raise or lower Medicare reimbursements based on scores.
However, MIPS “will not achieve the goal of identifying and rewarding high-value clinicians,” David V. Glass, a MedPAC principal policy analyst, said during the presentation. MedPAC makes recommendations to Congress and the CMS on Medicare policy, and lawmakers would have to change federal law to get rid of the reporting program.
A 2015 law, the Medicare Access and CHIP Reauthorization Act (MACRA), created a two-track system when it replaced the sustainable growth rate formula as the Part B payment methodology. MIPS is one of the two tracks, but doctors may avoid it by joining the other MACRA track—an advanced alternative payment model. The models, which include some accountable care organizations, are intended to get medical professionals out of the Medicare fee-for-service system and into one that rewards quality, rather than volume, of health-care services.
MACRA affects hundreds of thousands of professionals, but 800,000 are currently exempt for various reasons, including having a low volume of Medicare claims.
The Centers for Medicare & Medicaid Services offers professionals a wide range of MIPS measures on which to report. But since they can choose their own measures, comparisons are difficult. The measures themselves are not associated with high-value care, staff said.
Nearly all of the commissioners said that MIPS should either be repealed, or repealed and replaced.
“It’s a huge pain” and should be ended, Commissioner Rita Redberg, a professor of clinical medicine at the University of California at San Francisco Medical Center, said. People don’t go into medicine to check off boxes, she said.
“When I think of all the money that we pay to reward clinicians for their participation, I don’t think we’re getting value,” Commissioner Dana Gelb Safran, the chief performance measurement and improvement officer for Enterprise Analytics at Blue Cross Blue Shield of Massachusetts, said. The Medicare patient is not going to be getting better quality care or better outcomes as a result of MIPS, she said.
Commission staff discussed as a possible replacement a program in which doctors would have a portion of their Medicare fee schedule payments, suggested at 2 percent, withheld. They could then choose to join an alternative payment model and get the money returned.
They could also be measured on performance as part of a large group of clinicians. The measures would examine clinical quality, patient experience, and value. Medicare would be able to adjust funding for group members based on outcomes. But if doctors do nothing, they lose the withheld funds.
To contact the reporter on this story: Mindy Yochelson at MYochelson@bna.com
To contact the editor responsible for this story: Kendra Casey Plank at email@example.com
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)